Wednesday - September 17, 2025
Foley Hoag Guides Organogenesis in $130M Series A Convertible Preferred Stock PIPE
November 26, 2024
BOSTON, Massachusetts, Nov. 26 -- Foley Hoag, a law firm, issued the following news:

Foley Hoag LLP advised Organogenesis Holdings Inc. (Nasdaq: ORGO) ("Organogenesis"), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, in connection with its $130 million Series A Convertible Preferred Stock PIPE.

Foley Hoag attorney . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products